^
Association details:
Biomarker:GNAQ mutation
Cancer:Uveal Melanoma
Drug:FR900359 (Gαq-11 protein inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

656 GDP/GTP exchange inhibitor, FR900359, synergizes with chloroquine in GNAQ/11-mutant melanoma

Published date:
07/01/2020
Excerpt:
FR900359, was characterized to inhibit growth of GNAQ-mutant uveal melanoma cells in vitro, but has been limited in translatability due to a narrow therapeutic window. We show that FR900359 is a potent inducer of autophagy in GNAQ- and GNA11-mutant cell line...These findings provide a novel and potentially effective combination treatment approach for GNAQ/11-mutant melanomas.
DOI:
https://doi.org/10.1016/j.jid.2020.03.668